Repligen
RGEN
#2039
Rank
A$14.10 B
Marketcap
A$250.53
Share price
-0.46%
Change (1 day)
8.10%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of September 2025 : A$1.13 Billion

According to Repligen 's latest financial reports the company has A$1.13 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$1.21 B10.41%
2023-12-31A$1.10 B20.31%
2022-12-31A$0.91 B10.05%
2021-12-31A$0.83 B-10.72%
2020-12-31A$0.93 B23.61%
2019-12-31A$0.75 B174.3%
2018-12-31A$0.27 B23.62%
2017-12-31A$0.22 B13.16%
2016-12-31A$0.19 B99.64%
2015-12-31A$98.52 M37.94%
2014-12-31A$71.42 M3.38%
2013-12-31A$69.08 M79.24%
2012-12-31A$38.54 M
2011-03-31A$48.02 M-16.8%
2010-03-31A$57.71 M-17.43%
2009-03-31A$69.89 M29.32%
2008-03-31A$54.05 M93%
2007-03-31A$28 M4.72%
2006-03-31A$26.74 M20.08%
2005-03-31A$22.27 M20.25%
2004-03-31A$18.52 M-28.03%
2003-03-31A$25.73 M-34.11%
2002-03-31A$39.05 M-21.14%
2001-03-31A$49.52 M-12.18%
2000-03-31A$56.39 M983.15%
1999-03-31A$5.2 M-26.74%
1998-03-31A$7.1 M59.2%
1997-03-31A$4.46 M-49.28%
1996-03-31A$8.8 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novavax
NVAX
A$1.15 B 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.23 B 97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.68 B 48.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$20.41 B 1,704.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$5.35 B 373.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$24.94 B 2,103.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$22.64 B 1,901.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.21 B-80.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$44.76 M-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$0.31 B-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA